| Cell line name |
UOK350 |
|---|
| Accession |
CVCL_E7RE |
|---|
| Resource Identification Initiative |
To cite this cell line use: UOK350 (RRID:CVCL_E7RE) |
|---|
| Comments |
Doubling time: 48-72 hours (Direct_author_submission).
Miscellaneous: Doubling time and STR profile from personal communication of Yang, You-Feng.
Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175. |
|---|
| Sequence variations |
- Gene deletion; HGNC; HGNC:3700; FH; Zygosity=Heterozygous; Note=Spontaneous loss of heterozygosity (PubMed=33402335).
- Mutation; HGNC; HGNC:3700; FH; Simple; p.Val322Gly (c.965T>G); ClinVar=VCV000214417; Zygosity=Heterozygous (PubMed=33402335).
|
|---|
| Disease |
Hereditary leiomyomatosis and renal cell carcinoma (NCIt: C51302)
Hereditary leiomyomatosis and renal cell cancer (ORDO: Orphanet_523) |
|---|
| Species of origin |
Homo sapiens (Human)
(NCBI Taxonomy: 9606) |
|---|
| Sex of cell |
Male |
|---|
| Age at sampling |
37Y |
|---|
| Category |
Cancer cell line |
|---|
| STR profile |
Source(s): Direct_author_submission
Markers:| Amelogenin | X,Y |
| CSF1PO | 12 |
| D3S1358 | 14,16 |
| D5S818 | 11,12 |
| D7S820 | 10,13 |
| D8S1179 | 10,14 |
| D13S317 | 7,13 |
| D16S539 | 9,13 |
| D18S51 | 17,19 |
| D21S11 | 32.2 |
| FGA | 25 |
| Penta D | 9,12 |
| Penta E | 10 |
| TH01 | 7,9 |
| TPOX | 11 |
| vWA | 14,17 |
Run an STR similarity search on this cell line |
|---|
| Publications | PubMed=33402335; DOI=10.1126/scisignal.abc4436; PMCID=PMC8039187
Daniel R. Crooks, Nunziata Maio, Martin Lang, Christopher J. Ricketts, Cathy D. Vocke, Sandeep Gurram, Sevilay Turan, Yun-Young Kim, Geetha Mariah Cawthon, Ferri Sohelian, Natalia de Val ...Show all 27 authors... , Ruth Maria Pfeiffer, Parthav Jailwala, Mayank Tandon, Bao Tran, Teresa Whei-Mei Fan, Andrew N. Lane, Thomas Ried, Darawalee Wangsa Zong, Ashkan A. Malayeri, Maria J. Merino, You-Feng Yang, Jordan L. Meier, Mark W. Ball, Tracey Ann Rouault, Ramaprasad Srinivasan, William Marston Linehan; Show fewer authors
Mitochondrial DNA alterations underlie an irreversible shift to aerobic glycolysis in fumarate hydratase-deficient renal cancer.
Sci. Signal. 14:eabc4436.1-eabc4436.18(2021) |
|---|
| Entry history |
|---|
| Entry creation | 10-Apr-2025 |
|---|
| Last entry update | 10-Apr-2025 |
|---|
| Version number | 1 |
|---|
